Problem Solving Treatment for Diabetes in Individuals With Poor Diabetes Control
NCT ID: NCT05651490
Last Updated: 2022-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
106 participants
INTERVENTIONAL
2020-03-09
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To evaluate the clinical effectiveness of PST-D compared with the attention control group.
* To determine the impact of PST-D on patient-centred, behavioural, and psychosocial outcomes.
* To identify independent factors associated with an improvement in HbA1c and reductions in incidence and progression diabetic retinopathy, diabetic neuropathy, diabetic peripheral neuropathy, and visual impairment at 18-month follow-up in both groups; and determine if these factors mediate the associations between the PST-D intervention with the above outcomes.
* To quantify the incremental cost-effectiveness of PST-D compared with the attention control group at 18-month follow-up.
* To understand participants' views, experiences, and opinions about PST-D; and the barriers and facilitators to program completion.
Participants will complete blood tests, ocular examinations, and a series of questionnaires at baseline, 6-month, 12-month, and 18-month follow-up. Participants will also complete the intervention/ control group sessions conducted over the phone, video call, or face-to-face depending on the participant's preference.
Researchers will compare the intervention group against the attention control group to determine the effectiveness of PST-D on improving clinical, patient-centred, behavioural, and psychosocial outcomes.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Based on a previous trial on problem solving therapy in people with diabetic retinopathy and significant levels of distress, the investigators have designed a cognitive-behavioural intervention which aims to teach individuals skills to cope with and solve problems related to diabetes self-management. This novel intervention will be carried out at one tertiary hospital in Singapore, with the option for interested community-dwelling individuals with diabetes to participate, to facilitate its implementation and transition to the real world setting to assist patients with diabetes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group (PST-D)
Participants in the intervention group will receive usual care comprising of routine follow-up checks from their hospitals on top of the intervention (PST-D). The intervention consists of one introductory session, up to eight weekly treatment sessions, and three monthly maintenance sessions; these are individual sessions of approximately 30 to 45 minutes each and will be conducted over the phone, video call, or face-to-face depending on the participant's preference.
Problem Solving Treatment for Diabetes
In the introductory session, the structure of and rationale behind PST-D will be explained. The specialist will work with the participant to develop a problem list related to diabetes self-management and smoking cessation, if applicable.
During the weekly sessions, the participant will be taught and guided through the seven steps of problem solving:
1. Clarifying and defining the problem
2. Setting a realistic goal
3. Brainstorming multiple solutions
4. Generating pros and cons for each solution
5. Evaluating and choosing a preferred solution
6. Developing a specific action plan to implement the solution
7. Evaluating outcomes from the previous session.
Participants will also plan to engage in at least 1 enjoyable activity daily during the week.
The number of sessions will differ based on the specialist's assessment of the participant's problem-solving skills.
Maintenance sessions will be delivered monthly across 3 months in order to follow-up with participants.
Attention control group
The participants in the control group will receive usual care comprising of routine follow-up checks from their hospitals. They will also receive one introductory session and up to eight weekly treatment sessions; these are individual sessions of approximately 30 to 45 minutes each and will be conducted over the phone, video call, or face-to-face depending on the participant's preference.
Attention Control Group
During the sessions, the healthcare practitioners will provide general information and recommendations on general health topics such as oral health, hearing loss, sleep, dementia, adult vaccination, influenza, and dengue fever. Participants will also be given handouts adapted from government agencies and/or public bodies, such as HealthHub, National Health Service, National Addictions Management Service, and National Environmental Agency, on these topics. The healthcare practitioners will avoid discussing topics related to diabetes, diet, physical activity, and medication.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Problem Solving Treatment for Diabetes
In the introductory session, the structure of and rationale behind PST-D will be explained. The specialist will work with the participant to develop a problem list related to diabetes self-management and smoking cessation, if applicable.
During the weekly sessions, the participant will be taught and guided through the seven steps of problem solving:
1. Clarifying and defining the problem
2. Setting a realistic goal
3. Brainstorming multiple solutions
4. Generating pros and cons for each solution
5. Evaluating and choosing a preferred solution
6. Developing a specific action plan to implement the solution
7. Evaluating outcomes from the previous session.
Participants will also plan to engage in at least 1 enjoyable activity daily during the week.
The number of sessions will differ based on the specialist's assessment of the participant's problem-solving skills.
Maintenance sessions will be delivered monthly across 3 months in order to follow-up with participants.
Attention Control Group
During the sessions, the healthcare practitioners will provide general information and recommendations on general health topics such as oral health, hearing loss, sleep, dementia, adult vaccination, influenza, and dengue fever. Participants will also be given handouts adapted from government agencies and/or public bodies, such as HealthHub, National Health Service, National Addictions Management Service, and National Environmental Agency, on these topics. The healthcare practitioners will avoid discussing topics related to diabetes, diet, physical activity, and medication.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak English and/or Mandarin
* Singapore citizens or those with Singapore permanent residency status
* Aged 21 years and above
* No cognitive impairment, as assessed using the 6-item Cognitive Impairment Test (6CIT)
* Adequate hearing with/without hearing aids to respond to normal conversation
* Consent to participate in the sessions if randomised to the PST-D treatment arm
Exclusion Criteria
* All recent HbA1c readings are \<7.0%
* Uncontactable or unwilling/unable to participate in all the PST-D sessions if randomised to the PST-D group
21 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Singapore Eye Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ecosse Lamoureux
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ecosse Lamoureux, PhD
Role: PRINCIPAL_INVESTIGATOR
Singapore Eye Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Singapore Eye Research Institute
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R1596/95/2018
Identifier Type: -
Identifier Source: org_study_id